Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Reinvestment Rate
Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Reinvestment Rate of 1.57x as of December 2023, reinvesting $21.28 Million (capex $356.00K plus investments $20.93 Million) from operating cash flow of $13.55 Million. See Amylyx Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Amylyx Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see AMLX cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year capital reinvestment analysis for Amylyx Pharmaceuticals Inc. See Amylyx Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 13.28x | $158.29 Million | $11.92 Million | $1.24 Million | — |